See more : Warpaint London PLC (WPNTF) Income Statement Analysis – Financial Results
Complete financial analysis of Makers Laboratories Limited (MAKERSL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Makers Laboratories Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Oatly Group AB (OTLY) Income Statement Analysis – Financial Results
- Aequi Acquisition Corp. (ARBG) Income Statement Analysis – Financial Results
- Toung Loong Textile Mfg.Co.,Ltd. (4401.TWO) Income Statement Analysis – Financial Results
- Everbrite Technology Co., Ltd. (4523.TWO) Income Statement Analysis – Financial Results
- Software Aktiengesellschaft (SOW.DE) Income Statement Analysis – Financial Results
Makers Laboratories Limited (MAKERSL.BO)
About Makers Laboratories Limited
Makers Laboratories Ltd. is a pharmaceutical company, which engages in manufacturing and marketing of pharmaceutical products. Its formulation brands include Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin. The company was founded on July 9, 1984 and is headquartered in Mumbai, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.04B | 1.01B | 1.27B | 682.81M | 513.97M | 466.25M | 559.46M | 581.31M | 614.10M | 649.14M | 683.73M | 615.48M | 624.09M | 540.44M | 462.66M | 406.30M | 455.75M |
Cost of Revenue | 655.71M | 618.56M | 741.21M | 368.28M | 311.81M | 309.92M | 384.99M | 372.63M | 391.43M | 418.32M | 439.56M | 389.06M | 407.45M | 331.16M | 380.57M | 355.93M | 423.02M |
Gross Profit | 381.92M | 389.81M | 524.39M | 314.53M | 202.16M | 156.33M | 174.46M | 208.68M | 222.67M | 230.82M | 244.17M | 226.42M | 216.64M | 209.27M | 82.09M | 50.36M | 32.74M |
Gross Profit Ratio | 36.81% | 38.66% | 41.43% | 46.06% | 39.33% | 33.53% | 31.18% | 35.90% | 36.26% | 35.56% | 35.71% | 36.79% | 34.71% | 38.72% | 17.74% | 12.40% | 7.18% |
Research & Development | 1.27M | 2.58M | 5.27M | 2.38M | 274.00K | 293.00K | 450.00K | 107.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 15.12M | 11.53M | 11.72M | 8.26M | 3.40M | 3.78M | 3.05M | 3.23M | 3.43M | 2.08M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 42.58M | 44.02M | 59.14M | 35.75M | 35.01M | 544.00K | 1.42M | 28.62M | 31.99M | 38.95M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 57.70M | 55.55M | 70.87M | 44.00M | 38.42M | 4.32M | 4.47M | 31.85M | 35.42M | 41.03M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 322.95M | 6.75M | 13.47M | 1.64M | 619.00K | 19.35M | 12.57M | 1.87M | 2.03M | 1.79M | 2.54M | 2.52M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 381.92M | 397.11M | 373.49M | 269.45M | 191.05M | 144.44M | 141.96M | 164.88M | 185.63M | 200.43M | 233.48M | 198.07M | 215.25M | 152.17M | 31.09M | 9.08M | 10.09M |
Cost & Expenses | 1.04B | 1.02B | 1.11B | 637.73M | 502.86M | 454.36M | 526.95M | 537.51M | 577.06M | 618.75M | 673.04M | 587.13M | 622.70M | 483.33M | 411.66M | 365.01M | 433.10M |
Interest Income | 5.92M | 8.79M | 7.50M | 1.15M | 232.00K | 2.90M | 2.24M | 750.00K | 3.48M | 2.18M | 2.01M | 3.00M | 4.15M | 4.51M | 1.71M | 219.32K | 0.00 |
Interest Expense | 19.54M | 21.21M | 16.79M | 17.16M | 7.03M | 2.54M | 3.58M | 2.71M | 3.20M | 3.82M | 4.29M | 9.40M | 12.39M | 10.66M | 6.29M | 5.06M | 0.00 |
Depreciation & Amortization | 45.44M | 42.42M | 40.24M | 46.11M | 19.88M | 15.03M | 15.72M | 10.77M | 12.50M | 15.27M | 9.73M | 10.11M | 10.18M | 7.05M | 1.79M | 1.30M | 2.84M |
EBITDA | 25.81M | 48.79M | 214.06M | 89.24M | 29.41M | 47.76M | 61.66M | 66.87M | 51.10M | 46.06M | 25.90M | 54.40M | 16.11M | 67.70M | 52.80M | 42.59M | 25.50M |
EBITDA Ratio | 2.49% | 5.65% | 17.05% | 14.18% | 6.37% | 11.03% | 11.61% | 10.18% | 9.00% | 7.73% | 3.78% | 7.26% | 2.56% | 12.76% | 11.41% | 10.48% | 5.59% |
Operating Income | -34.91M | -9.50M | 150.07M | 35.20M | 10.51M | 10.17M | 30.33M | 43.64M | 31.34M | 34.91M | 16.11M | 34.59M | 5.83M | 61.93M | 51.00M | 41.29M | 22.65M |
Operating Income Ratio | -3.36% | -0.94% | 11.86% | 5.16% | 2.04% | 2.18% | 5.42% | 7.51% | 5.10% | 5.38% | 2.36% | 5.62% | 0.93% | 11.46% | 11.02% | 10.16% | 4.97% |
Total Other Income/Expenses | -4.26M | 1.12M | 6.82M | -8.16M | -8.62M | 18.27M | 9.85M | 9.56M | -2.01M | 3.61M | -4.24M | 6.53M | -7.84M | -5.78M | -4.57M | -4.84M | -5.84M |
Income Before Tax | -39.17M | -8.39M | 156.88M | 27.05M | 2.49M | 30.16M | 42.36M | 53.36M | 35.03M | 34.00M | 11.88M | 34.88M | -6.45M | 51.32M | 46.43M | 36.45M | 16.81M |
Income Before Tax Ratio | -3.77% | -0.83% | 12.40% | 3.96% | 0.48% | 6.47% | 7.57% | 9.18% | 5.70% | 5.24% | 1.74% | 5.67% | -1.03% | 9.50% | 10.03% | 8.97% | 3.69% |
Income Tax Expense | 8.94M | 13.53M | 39.71M | 13.56M | 3.73M | 5.67M | 11.79M | 16.37M | 11.97M | 10.48M | 5.92M | 10.47M | -730.64K | 16.78M | 18.45M | 12.98M | 5.59M |
Net Income | -62.64M | -47.51M | 49.78M | -3.29M | -1.24M | 24.49M | 30.57M | 37.00M | 23.06M | 23.52M | 5.96M | 24.41M | -5.72M | 34.54M | 27.97M | 23.86M | -2.04M |
Net Income Ratio | -6.04% | -4.71% | 3.93% | -0.48% | -0.24% | 5.25% | 5.46% | 6.36% | 3.76% | 3.62% | 0.87% | 3.97% | -0.92% | 6.39% | 6.05% | 5.87% | -0.45% |
EPS | -10.62 | -7.90 | 10.12 | -0.64 | -0.24 | 4.78 | 5.97 | 7.22 | 4.50 | 4.59 | 1.16 | 4.77 | -1.12 | 6.75 | 6.18 | 5.27 | -0.45 |
EPS Diluted | -10.62 | -7.90 | 10.12 | -0.64 | -0.24 | 4.78 | 5.97 | 7.22 | 4.50 | 4.59 | 1.16 | 4.77 | -1.12 | 6.75 | 6.18 | 5.27 | -0.45 |
Weighted Avg Shares Out | 5.90M | 6.01M | 4.92M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 4.53M | 4.53M |
Weighted Avg Shares Out (Dil) | 5.90M | 6.01M | 4.92M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 5.12M | 4.53M | 4.53M |
Source: https://incomestatements.info
Category: Stock Reports